Nonsteroidal Anti-inflammatory Drug (NSAID) Tolerance After Biological Therapy in Patients With NSAID-Exacerbated Respiratory Disease: A Randomized Comparative Trial
The Journal of Allergy and Clinical Immunology In Practice2023Vol. 11(7), pp. 2172–2179
Citations Over TimeTop 10% of 2023 papers
Related Papers
- → [SWITCHING BIOLOGICS LED TO GOOD CONTROL IN SEVERE CHILDHOOD ASTHMA: A CASE REPORT].(2019)6 cited
- → Efficacy of mepolizumab and omalizumab combination therapy in uncontrolled asthma(2023)6 cited
- → P234 Combination omalizumab and mepolizumab therapy for poorly-controlled severe persistent asthma(2017)5 cited
- → Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab(2021)6 cited
- → Real-Life Data on the Use of Omalizumab in Patients with Severe Asthma and Chronic Urticaria and Mepolizumab in Patients with Severe Asthma: A Retrospective Study(2023)